These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31646769)

  • 1. Ideal Target Blood Pressure in Hypertension.
    Park S
    Korean Circ J; 2019 Nov; 49(11):1002-1009. PubMed ID: 31646769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure.
    Park S
    Korean J Intern Med; 2019 Jan; 34(1):44-49. PubMed ID: 30612417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.
    Gijón-Conde T; Sánchez-Martínez M; Graciani A; Cruz JJ; López-García E; Ortolá R; Rodríguez-Artalejo F; Banegas JR
    J Hypertens; 2019 Jul; 37(7):1393-1400. PubMed ID: 31145710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering the systolic blood pressure target in hypertensive patients: current controversies and future outlook.
    Narita K; Hoshide S; Kario K
    Expert Rev Cardiovasc Ther; 2018 Dec; 16(12):889-895. PubMed ID: 30358459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.
    Chiang CE; Wang TD; Ueng KC; Lin TH; Yeh HI; Chen CY; Wu YJ; Tsai WC; Chao TH; Chen CH; Chu PH; Chao CL; Liu PY; Sung SH; Cheng HM; Wang KL; Li YH; Chiang FT; Chen JH; Chen WJ; Yeh SJ; Lin SJ
    J Chin Med Assoc; 2015 Jan; 78(1):1-47. PubMed ID: 25547819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
    Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal blood pressure targets for patients with hypertension: a systematic review and meta-analysis.
    Sakima A; Satonaka H; Nishida N; Yatsu K; Arima H
    Hypertens Res; 2019 Apr; 42(4):483-495. PubMed ID: 30948822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 - benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2018 Aug; 36(8):1622-1636. PubMed ID: 29847485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension Control and Guideline-Recommended Target Blood Pressure Goal Achievement at an Early Stage of Hypertension in the UAE.
    Bhagavathula AS; Shah SM; Suliman A; Oulhaj A; Aburawi EH
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines?　- An Asian Perspective.
    Ihm SH; Bakris G; Sakuma I; Sohn IS; Koh KK
    Circ J; 2019 Feb; 83(3):504-510. PubMed ID: 30606943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Apr; 34(4):613-22. PubMed ID: 26848994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension.
    Kim BK; Rhee MY
    Healthcare (Basel); 2020 May; 8(2):. PubMed ID: 32375221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the New 2017 American College of Cardiology/American Heart Association Guidelines for Hypertension.
    Aronow WS
    Minerva Cardioangiol; 2019 Oct; 67(5):399-410. PubMed ID: 31220914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing Heart Failure by Treating Systolic Hypertension: What Does the SPRINT Add?
    Upadhya B; Stacey RB; Kitzman DW
    Curr Hypertens Rep; 2019 Jan; 21(1):9. PubMed ID: 30659372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Pressure Change from Normal to 2017 ACC/AHA Defined Stage 1 Hypertension and Cardiovascular Risk.
    Son JS; Choi S; Lee G; Jeong SM; Kim SM; Kim K; Yun JM; Park SM
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31181795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Aug; 34(8):1451-63. PubMed ID: 27228434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure: overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 Nov; 35(11):2138-2149. PubMed ID: 28858983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.